Industri

Off label drug use and physician liability

Dr Amit Kumar, Assistant Professor of Law, Maharashtra National Law University ...

Supriya Lifescience receives USFDA EIR with VAI classif...

Inspection cycle closed following February 2026 USFDA audit The post Supriya Li...

Lupin launches Dapagliflozin and Metformin extended-rel...

USFDA approves ANDA for bioequivalent version of Xigduo XR The post Lupin laun...

How Does Rubber Flooring Support Patient Safety and Exp...

Flooring is foundational and sets the tone for the space while also meeting the ...

Why Enterprise EHR Integrations Fail After Go-Live (And...

Healthcare organizations spend months, sometimes years, preparing for EHR integr...

Pfizer and Astellas secure FDA priority review for Padc...

The application aims to allow the use of this combination therapy for all patien...

Asahi Kasei acquires German company Aicuris

The move comes after Asahi Kasei signed a definitive agreement to acquire all is...

OneSource and Orbicular secure USFDA tentative approval...

Partnership progresses ANDA filing for generic version of Ozempic with manufact...

Zyax Chem acquires 26% stake in Gaymed Labs

Investment brings board representation and expansion plans in ophthalmic segmen...

India’s biopharma moment—If we get the ecosystem right

Krishna Sarma highlights the ecosystem requirements for advancing biopharma inn...

Tennessee Lawmakers Approve $311 Million for New UT Hea...

State lawmakers have approved $311 million in funding for a new College of Medic...

UCB to purchase Neurona and NRTX-1001 for $1.15bn

The deal value comprises an upfront payment of up to $650m and up to $500m in fu...

MSD secures EC approval for Enflonsia to prevent infant...

This approval authorises Enflonsia’s marketing across all 27 European Union memb...

Clinical exclusivity for indigenous medicines can impro...

Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clin...

Morepen Laboratories clears fourth USFDA inspection at ...

Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing eng...

Rusan Pharma secures PMDA GMP approval for Ankleshwar a...

Approval from Japan regulator covers API and finished dosage manufacturing unit...